JUNO

Juno Therapeutics, Inc.
JUNO

Delisted

JUNO was delisted on the 5th of March, 2018.

158 hedge funds and large institutions have $2.34B invested in Juno Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 52 increasing their positions, 45 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
158
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$46.6M
Puts
$24.6M
Net Calls
Net Calls Change

Top Buyers

1 +$405M
2 +$37.8M
3 +$37.6M
4
Ameriprise
Ameriprise
Minnesota
+$19.1M
5
Millennium Management
Millennium Management
New York
+$9.66M

Top Sellers

1 -$324M
2 -$60.4M
3 -$44.6M
4
BAMCO Inc
BAMCO Inc
New York
-$8.79M
5
Goldman Sachs
Goldman Sachs
New York
-$8.7M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$1.74M
52
$1.52M
53
$1.51M
54
$1.49M
55
$1.49M
56
$1.48M
57
$1.46M
58
$1.44M
59
$1.41M
60
$1.32M
61
$1.3M
62
$1.27M
63
$1.14M
64
$1.1M
65
$1.05M
66
$1.04M
67
$964K
68
$948K
69
$947K
70
$919K
71
$834K
72
$824K
73
$819K
74
$739K
75
$721K